FDAFDA · Food and drugs·Recall number D-0181-2023
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
Published February 1, 2023 · Recall initiated: December 6, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Distributor
- Nationwide in the USA.
- Lot
- a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.